CellSeed Inc. (TYO:7776)
Japan · Delayed Price · Currency is JPY 349.00
-5.00 (-1.41%)
At close: Mar 6, 2026
CellSeed Market Cap
CellSeed has a market cap or net worth of 12.9 billion as of March 6, 2026. Its market cap has decreased by -6.26% in one year.
Market Cap
12.90B
Enterprise Value
n/a
Revenue
161.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
349.00
Market Cap Chart
Since March 16, 2010, CellSeed's market cap has increased from 5.26B to 12.90B, an increase of 145.13%. That is a compound annual growth rate of 5.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 12.90B | 43.69% |
| Dec 30, 2025 | 8.98B | -35.09% |
| Dec 30, 2024 | 13.83B | 62.71% |
| Dec 29, 2023 | 8.50B | 107.22% |
| Dec 30, 2022 | 4.10B | 25.55% |
| Dec 30, 2021 | 3.27B | -13.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemRIM | 18.62B |
| ReproCELL | 16.76B |
| Stella Pharma | 15.96B |
| Kubota Pharmaceutical Holdings | 15.58B |
| CanBas | 15.21B |
| Nano Holdings | 13.50B |
| Immuno-Biological Laboratories | 13.40B |
| Kidswell Bio | 12.35B |